Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuo-How Huang

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|October 6, 2018
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinomaWei-Chou Lin, Fu-Shun Hsu, Kuan-Lin Kuo, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 12, 2019
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinomaWei-Chou Lin, Fu-Shun Hsu, Kuan-Lin Kuo, et al.
Scientific Reports|January 23, 2020
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical ProstatectomyYung-Ting Cheng, Chao-Yuan Huang, Chung-Hsin Chen, et al.
Therapeutic Advances in Chronic Disease|February 16, 2024
Synergistic effect of albuminuria on atherosclerosis in patients with primary aldosteronismTing-Wei Kao, Che-Wei Liao, Cheng-Hsuan Tsai, et al.
The Journal of Clinical Endocrinology and Metabolism|January 2, 2025
The Captopril Challenge Test Predicts Cardiac Structure and Dysfunction in Primary AldosteronismUei-Lin Chen, Che-Wei Liao, Shuo-Meng Wang, et al.
Therapeutic Advances in Chronic Disease|January 23, 2023
Mineralocorticoid receptor antagonist treatment improved arterial stiffness in patients with primary aldosteronism: a cohort study compared with adrenalectomyChe-Wei Liao, Yen-Tin Lin, Cheng-Hsuan Tsai, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 25, 2009
Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma, Vin-Cent Wu, Shih-Chieh Chueh, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2010
Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activityVin-Cent Wu, Chin-Chi Kuo, Hung-Wei Chang, et al.
American Journal of Cancer Research|January 26, 2016
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo studyWei-Chou Lin, Kuan-Lin Kuo, Chung-Sheng Shi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 16, 2022
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosisHui-Teng Cheng, Hsi-Chien Huang, Tsung-Ying Lee, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Journal of Molecular Medicine (Berlin, Germany)|October 6, 2018
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinomaWei-Chou Lin, Fu-Shun Hsu, Kuan-Lin Kuo, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 12, 2019
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinomaWei-Chou Lin, Fu-Shun Hsu, Kuan-Lin Kuo, et al.
Scientific Reports|January 23, 2020
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical ProstatectomyYung-Ting Cheng, Chao-Yuan Huang, Chung-Hsin Chen, et al.
Therapeutic Advances in Chronic Disease|February 16, 2024
Synergistic effect of albuminuria on atherosclerosis in patients with primary aldosteronismTing-Wei Kao, Che-Wei Liao, Cheng-Hsuan Tsai, et al.
The Journal of Clinical Endocrinology and Metabolism|January 2, 2025
The Captopril Challenge Test Predicts Cardiac Structure and Dysfunction in Primary AldosteronismUei-Lin Chen, Che-Wei Liao, Shuo-Meng Wang, et al.
Therapeutic Advances in Chronic Disease|January 23, 2023
Mineralocorticoid receptor antagonist treatment improved arterial stiffness in patients with primary aldosteronism: a cohort study compared with adrenalectomyChe-Wei Liao, Yen-Tin Lin, Cheng-Hsuan Tsai, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 25, 2009
Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma, Vin-Cent Wu, Shih-Chieh Chueh, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2010
Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activityVin-Cent Wu, Chin-Chi Kuo, Hung-Wei Chang, et al.
American Journal of Cancer Research|January 26, 2016
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo studyWei-Chou Lin, Kuan-Lin Kuo, Chung-Sheng Shi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 16, 2022
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosisHui-Teng Cheng, Hsi-Chien Huang, Tsung-Ying Lee, et al.
Pageof 20